Showing results (1531-1540 of 1,709) with videos related to
Sort By:
Pageof 171
Blood|December 6, 2019
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in childrenLeonardo R Brandão, Manuela Albisetti, Jacqueline Halton, et al.Scientific Reports|January 9, 2021
Advanced characterization of biomineralization at plaque layer and inside rice roots amended with iron- and silica-enhanced biocharGuanhong Chen, Sarasadat Taherymoosavi, Soshan Cheong, et al.Journal of Thoracic Disease|June 11, 2019
Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer DatabaseDavid B Nelson, David C Rice, Kyle G Mitchell, et al.Journal of Pediatric Psychology|May 2, 1998
Hemophilia growth and development study: relationships between neuropsychological, neurological, and MRI findings at baselineP A Sirois, D W Usner, S D Hill, et al.Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 14, 2017
2017 Version of LI-RADS for CT and MR Imaging: An UpdateKhaled M Elsayes, Jonathan C Hooker, Michelle M Agrons, et al.The Annals of Thoracic Surgery|August 18, 2018
Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and WomenDavid B Nelson, Danica J Lapid, Kyle G Mitchell, et al.Familial Cancer|May 10, 2020
Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinicsB Meiser, R Kaur, J Kirk, et al.The Journal of Thoracic and Cardiovascular Surgery|March 18, 2018
Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patientsBoris Sepesi, Yuanqing Ye, Kyle G Mitchell, et al.The Medical Journal of Australia|November 15, 2020
Ending rheumatic heart disease in Australia: the evidence for a new approachRosemary Wyber, Katharine Noonan, Catherine Halkon, et al.Cancer|January 9, 2003
A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) StudyLesley G Mitchell, Maureen Andrew, Kim Hanna, et al.Pageof 171